← Articles Business

Amyris Plans to Acquire Sweet Protein Startup Oobli

Oobli, which uses a fermentation process to produce sweet proteins from rare equatorial fruits, is set to join Amyris in a deal the company frames as accelerating wider commercialization of its sweetener technology.

· Oobli · Amyris

Sweetness potency
Sweet proteins up to 5,000x sweeter than sugar, per the company
Sugar replacement range
Can replace up to 90% of sugar in formulations, per the company
Consumer products
DTC chocolate bars priced from $11.99; in-flight on Japan Airlines
Leadership
CEO Ali Wing; Founder and CTO Dr. Jason Ryder
Deal status
Acquisition announced; Oobli to join Amyris, per the company

Oobli, a food technology startup producing sweet proteins via fermentation, has announced plans to join Amyris in a deal the company describes on its website as "accelerating the sweet revolution."

Oobli's ingredients are sweet proteins naturally found in rare fruits and berries near the equator. The company sells reduced-sugar chocolate bars directly to consumers, with individual SKUs priced between $11.99 and $21.99, and has secured in-flight placement on Japan Airlines, per its website. Oobli is led by CEO Ali Wing and Founder and CTO Dr. Jason Ryder.

The planned acquisition brings together Oobli's fermentation technology and Amyris' capabilities in a combination the brand's own pages frame as a path to wider commercialization of the sweetener across food and beverage categories.

Why it matters

The alternative sweetener category has attracted strong formulator interest for years, with stevia, monk fruit and allulose each gaining traction but carrying taste, labeling or bulking constraints that have limited their reach in mainstream CPG. Sweet proteins represent a structurally distinct approach: the sweetening molecule is a protein rather than a carbohydrate or glycoside, which opens different regulatory and labeling pathways for manufacturers. Oobli has also moved beyond ingredient supply to build a direct-to-consumer chocolate business, giving any acquirer proof-of-concept at the finished-goods level alongside the upstream technology. For CPG brands navigating sugar-reduction mandates and reformulation pressure, the deal signals that the sweetener space is entering a consolidation phase rather than simply accumulating startup investment.

What to watch

The central open question is whether the announced transaction closes and, if so, whether scale-up through Amyris's manufacturing infrastructure can bring sweet protein ingredient costs to a level competitive with incumbent natural sweeteners in mass-market applications.

Featured on @cpglatest: see the post

Sources

The CPG Latest brief

Breakout brands. Big deals. Retail wins.
Get the consumer business news worth knowing.